Safety and effectiveness of disease-modifying therapies after switching from natalizumab. Zeineddine M, Al-Roughani R, Farouk Ahmed S, Khoury S, et al. Mult Scler 2024;30:1026-1035.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeineddine M, Al-Roughani R, Farouk Ahmed S, Khoury S, et al. Safety and effectiveness of disease-modifying therapies after switching from natalizumab. Mult Scler 2024;30:1026-1035.
PMID: 39054846